primary immune thrombocytopenia is an acquired bleeding disorder with no clinically apparent cause of thrombocytopenia. clinical indicators of itp include easy bruising of the skin, prolonged bleeding on injury, mucocutaneous lesions such as petechiae and ecchymosis, epistaxis, gastrointestinal bleeding, hematuria and bleeding from the gums. it is important for a dentist to be aware of the clin...

background & aims of the study: corrosion and scaling play undesirable effects on transmission and distribution system of drinking water. the aim of this study was to assess the corrosion and scaling potential of drinking water resources in babol city. materials and methods: totally, 54 water samples were collected from 27 wells in spring and autumn. calciu m hardness, ph, total alkalinity, tot...

oriental hybrid lily “arabian red” mother scales were stored in moist cocopeat and perlite (1:1) for 3 or 5 months at 25 ̊c. the numbers of scale bulblets per mother scale were nearly identical in two durations. increasing storage duration promoted the growth of roots (number and length) and no. scales per scale bulblets. and, diameters of scale bulblets were more in longer storage duration (5 m...

BACKGROUND In recent years, several path-breaking findings on human mobility patterns point out a novel issue which is of important theoretical significance and great application prospects. The empirical analysis of the data which can reflect the real-world human mobility provides the basic cognition and verification of the theoretical models and predictive results on human mobility. One of the...

The Scaling Law for the Discrete Kinetic Growth Percolation Model The critical exponent of the total number of finite clusters α is calculated directly without using scaling hypothesis both below and above the percolation threshold pc based on a kinetic growth percolation model in two and three dimensions. Simultaneously, we can calculate other critical exponents β and γ, and show that the scal...

background: considering the increasing number of patients with hemophilia and infrastructure requirements for a comprehensive approach, development of a recombinant factor has become a milestone. the objective of this study was to assess the safety, efficacy and non inferiority of safacto (recombinant factor viii) compared with plasma-derived factor in the treatment of hemophilia a. methods: 10 ...